#ASGCT21 is available on demand until August 13!
Access the Meeting Platform

Helixmith Co., Ltd.

La Jolla,  CA 
United States

Welcome to Helixmith's virtual exhibit listing!

Helixmith is a gene therapy company developing new and innovative biopharmaceuticals for previously untreated diseases. The company has an extensive gene therapy pipeline, including a CAR-T program targeting several different types of solid tumors and an AAV vector program targeting neuromuscular diseases. Engensis (VM202), the most advanced pipeline candidate, is a plasmid DNA therapy being studied for painful diabetic peripheral neuropathy, diabetic foot ulcers, claudication, amyotrophic lateral sclerosis, coronary artery disease, and Charcot-Marie-Tooth disease.